Hawaii, Maryland and Ohio are the latest to join in extending postpartum Medicaid and Children's Health Insurance Program coverage for 12 months after pregnancy. In total, 21 states have adopted an extension.
Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there's a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.
We personally invite you to join us at Pegasus Park in Dallas on Wednesday, September 28 to partake in thought provoking panel discussions. Plus, this event offers an 6:1 ratio of attendees to investors for those seeking funding and a desire to network.
Don't miss this valuable opportunity to save $100 with our Early Bird Rate (ends 8/26).
The FDA has approved Axsome Therapeutics drug Auvelity as a treatment for major depressive disorder in adults. The regulatory decision makes the twice-daily pill the first new oral drug approved to address a novel depression target in more than 60 years.
Contract developer Minnetronix Medical recently developed and commercialized its own product: MindsEye, which it says is the first minimally invasive deep brain access port. The port addresses an unmet need in the neurology market — certain forms of stroke and cancer cause lesions that are deep in the brain, and removing them can be a very invasive and dangerous process.
By Robert Hamilton Friday, August 19, 2022 9:00 AM
Advanced technologies, such as AI-guided robotics and automation, offer a potential solution to the provider shortage by freeing healthcare professionals from repetitive and time-consuming tasks and allow clinicians to focus on tasks that require a specialized touch.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments